Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Mediwound Ltd Ord Sh
(NQ:
MDWD
)
18.36
+0.70 (+3.96%)
Streaming Delayed Price
Updated: 3:50 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
68,100
Open
17.83
Bid (Size)
18.29 (4)
Ask (Size)
18.42 (4)
Prev. Close
17.66
Today's Range
17.64 - 18.50
52wk Range
7.100 - 18.75
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences
April 25, 2024
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Ltd. (NASDAQ: MDWD) Sets New 52-Week High in Wednesday Session
April 17, 2024
Via
Investor Brand Network
Performance
YTD
+63.20%
+63.20%
1 Month
+17.99%
+17.99%
3 Month
+42.55%
+42.55%
6 Month
+135.38%
+135.38%
1 Year
+62.77%
+62.77%
More News
Read More
MDWD Stock Earnings: MediWound Beats EPS, Beats Revenue for Q4 2023
March 21, 2024
Via
InvestorPlace
MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
March 21, 2024
From
MediWound Ltd.
Via
GlobeNewswire
Preview: MediWound's Earnings
March 20, 2024
Via
Benzinga
Recap: MediWound Q3 Earnings
November 21, 2023
Via
Benzinga
Earnings Outlook For MediWound
November 20, 2023
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for MediWound: Here's What You Need To Know
September 21, 2023
Via
Benzinga
Earnings Scheduled For March 21, 2024
March 21, 2024
Via
Benzinga
MediWound to Report Fourth Quarter and Full Year 2023 Financial Results
March 14, 2024
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study
February 12, 2024
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Participate in Two Upcoming Investor Conferences
February 05, 2024
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal Burns
January 09, 2024
From
MediWound Ltd.
Via
GlobeNewswire
Innovative Burn Care: MediWound Bags Additional DoD Grant For NexoBrid Development
December 28, 2023
Via
Benzinga
MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army
December 28, 2023
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces Peer-Reviewed Publication of EscharEx® Mechanism of Action Study Assessing Its Effects on Biofilm and Microbial Loads
December 21, 2023
From
MediWound Ltd.
Via
GlobeNewswire
Earnings Scheduled For November 21, 2023
November 21, 2023
Via
Benzinga
MediWound Reports Third Quarter 2023 Financial Results and Provides Company Update
November 21, 2023
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer
November 21, 2023
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Report Third Quarter 2023 Financial Results
November 14, 2023
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Receives Positive CHMP Opinion Recommending Approval for NexoBrid® to Treat Pediatric Patients
November 13, 2023
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces a Collaboration with PolyMedics Innovations (PMI) for NexoBrid® Distribution in Europe
November 08, 2023
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces Collaboration with 3M on EscharEx® Phase III Study
October 11, 2023
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Deploys NexoBrid® for Emergency Supply
October 09, 2023
From
MediWound Ltd.
Via
GlobeNewswire
Q4 Stock Predictions: 3 Micro-Cap Stocks Ready to Skyrocket Into 2024
October 03, 2023
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.